ABVC (ABVC BioPharma Inc) Margin dodolan resik

Simbol resmi perusahaan ABVC BioPharma Inc (ABVC)

ABVC BioPharma revenues are based on licenses and milestone payments for the development of biologics targeting oncology and depression. Management is currently adapting the product portfolio to meet market demand while anticipating investor support. Net marginal sales income demonstrates business efficiency, where the value of 0.00 serves as the current metric, and growth is accelerating through partnerships with Asian medical centers to implement plant extracts.

ABVC: Tingkat bathi resik ABVC BioPharma, Inc 04.07.2022 - 19.11.2026

Ringkesan rincian data analitis ABVC BioPharma, Inc (ABVC)

- rega saham lan konsensus proyeksi valuasi:
Analisis komprehensif perusahaan:ABVC BioPharma
Barang unggulan ABVC BioPharma Inc

This indicator determines the share of net profit in every dollar of revenue, reflecting the overall efficiency of operating activities. For ABVC BioPharma (ABVC), this metric confirms the ability to monetize developments in oncology and neurology while accounting for R&D costs. The net profit margin trend allows for an assessment of the diversified portfolio's impact on profitability. The stability of this figure demonstrates the business model's resilience to market fluctuations, ensuring the long-term preservation and growth of invested capital.

Perusahaan pesaing

HLN: Margin dodolan resik|Rentabilitas dodolan resik KVUE|Margin resik veronapharma.com|Rentabilitas dodolan resik MENS (Jyong Biotech Corp)|Margin resik Ligand (LGND)|Margin dodolan resik amneal.com (AMRX)|Margin dodolan resik PRGO (perrigo.com)|Alvotech SA (ALVO) - Margin resik|Liquidia Inc. - Margin dodolan resik|Tingkat bathi miturut bathi resik Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Margin resik|Rentabilitas dodolan resik MNKD|Margin resik Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Margin dodolan perusahaan|Margin dodolan resik SPRY|TBPH - Margin resik|Aquestive Pharma - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik scpharmaceuticals.com SCPH|Tectonic - Margin dodolan resik|TNXP - Margin dodolan resik|SXTC: Margin dodolan resik|Eupraxia Pharma - Tingkat bathi resik|BHST (bioharvest.com) - Margin dodolan resik|Rentabilitas dodolan resik EXOZ (invizyne.com)|Margin dodolan resik ORMP|Margin dodolan perusahaan Entera Bio|Margin dodolan resik HYFT (MindWalk Holdings, Inc.)|CPIX - Rentabilitas dodolan miturut bathi resik|Quantum BioPharma Corp - Margin dodolan resik|FGEN (fibrogen.com) - Rentabilitas dodolan resik|TELO (Telomir Pharmaceuticals) - Rentabilitas dodolan miturut bathi resik|Rani Therapeutics Holdings - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik SNYR|Margin resik rallybio.com RLYB|Margin dodolan resik LEXX|PULM (Pulmatrix, Inc.) - Tingkat bathi resik|Pheton Holdings - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Aptorum Group Limited APM|LYRA: Rentabilitas dodolan miturut bathi resik|IBO: Margin resik|TNFA: Margin dodolan resik|YCBD: Rentabilitas resik perusahaan|Margin resik PainReform Ltd|CYTO (altamiratherapeutics.com) - Rentabilitas resik perusahaan|Margin dodolan resik LIPO|OPTN - Margin resik|Margin resik pieris.com PIRS|Tingkat bathi resik PROC|PTPI - Margin resik|Qilian International Holding (QLI) - Rentabilitas dodolan miturut bathi resik|SLRN: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik TFF Pharma